gabexate has been researched along with Skin Ulcer in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Skin Ulcer: An ULCER of the skin and underlying tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yuasa, T | 1 |
| Taniguchi, Y | 1 |
| Yamada, E | 1 |
| Inachi, S | 1 |
| Shimizu, M | 1 |
1 review available for gabexate and Skin Ulcer
| Article | Year |
|---|---|
Severe cutaneous and venous damage after DIC therapy.
Topics: Aged; Anticoagulants; Disseminated Intravascular Coagulation; Female; Gabexate; Humans; Necrosis; Sa | 1997 |